Perrigo Company (NYSE:PRGO) will announce its earnings results before the market opens on Thursday, August 10th. Analysts expect the company to announce earnings of $0.94 per share for the quarter. Perrigo has set its FY17 guidance at $4.15-4.50 EPS.

Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Tuesday, May 30th. The company reported $1.05 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.06. Perrigo had a negative net margin of 43.81% and a positive return on equity of 11.79%. The firm had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.19 billion. During the same quarter last year, the business earned $1.32 earnings per share. The business’s revenue for the quarter was down 11.4% compared to the same quarter last year. On average, analysts expect Perrigo to post $4.27 EPS for the current fiscal year and $5.02 EPS for the next fiscal year.

Shares of Perrigo Company (PRGO) opened at 67.51 on Tuesday. The company has a 50 day moving average of $74.16 and a 200 day moving average of $73.30. Perrigo Company has a 52 week low of $65.47 and a 52 week high of $99.14. The firm’s market cap is $9.68 billion.

PRGO has been the subject of a number of recent analyst reports. Deutsche Bank AG decreased their target price on shares of Perrigo from $87.00 to $86.00 and set a “buy” rating for the company in a research report on Wednesday, April 19th. Canaccord Genuity set a $86.00 target price on shares of Perrigo and gave the company a “buy” rating in a research report on Monday, May 22nd. Cantor Fitzgerald set a $85.00 target price on shares of Perrigo and gave the company a “buy” rating in a research report on Monday, July 24th. ValuEngine lowered shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Royal Bank Of Canada reiterated a “hold” rating and issued a $66.00 target price on shares of Perrigo in a research report on Wednesday, May 24th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $84.97.

TRADEMARK VIOLATION NOTICE: This report was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this report can be viewed at

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Earnings History for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with's FREE daily email newsletter.